TY - JOUR
T1 - Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever
AU - Zaks, Nurit
AU - Shinar, Yael
AU - Padeh, Shai
AU - Lidar, Merav
AU - Mor, Adam
AU - Tokov, Irena
AU - Pras, Mordechai
AU - Langevitz, Pnina
AU - Peras, Elon
AU - Livneh, Avi
PY - 2003/8/1
Y1 - 2003/8/1
N2 - Background: Familial Mediterranean fever is an autosomal recessive disease characterized by recurrent attacks of fever and serositis. The disease is caused by mutations in the MEFV gene, presumed to act as a down-regulator of inflammation within the polymorphonuclear cells. Objectives: To present the results of 412 FMF patients genotyped for three MEFV mutations, M694V, V726A and E148Q. Results: The most frequent mutation, M694V, was detected in 47% of the carrier chromosomes. This mutation, especially common among North African Jewish FMF patients, was not found in any of the Ashkenazi (East European origin) patients. Overall, one of the three mutations was detected in 70% of the carrier chromosomes. M694V/M694V was the most common genotype (27%), followed by M694V/V728A (18%). The full genotype could be assessed in 57% of the patients, and one disease-causing mutation in an additional 26%. Only one patient with the E148Q/E148Q genotype was detected despite a high carrier rate for this mutation in the Jewish population, a finding consistent with a low penetrance of this genotype. The M694V/M694V genotype was observed in 15 patients with amyloidosis compared to 4 amyloidosis patients with other genotypes (P < 0.0001). Conclusions: Because of low penetrance and as yet other undetermined reasons, mutation analysis of the most common MEFV mutations supports a clinical diagnosis in only about 60% of patients with definite FMF.
AB - Background: Familial Mediterranean fever is an autosomal recessive disease characterized by recurrent attacks of fever and serositis. The disease is caused by mutations in the MEFV gene, presumed to act as a down-regulator of inflammation within the polymorphonuclear cells. Objectives: To present the results of 412 FMF patients genotyped for three MEFV mutations, M694V, V726A and E148Q. Results: The most frequent mutation, M694V, was detected in 47% of the carrier chromosomes. This mutation, especially common among North African Jewish FMF patients, was not found in any of the Ashkenazi (East European origin) patients. Overall, one of the three mutations was detected in 70% of the carrier chromosomes. M694V/M694V was the most common genotype (27%), followed by M694V/V728A (18%). The full genotype could be assessed in 57% of the patients, and one disease-causing mutation in an additional 26%. Only one patient with the E148Q/E148Q genotype was detected despite a high carrier rate for this mutation in the Jewish population, a finding consistent with a low penetrance of this genotype. The M694V/M694V genotype was observed in 15 patients with amyloidosis compared to 4 amyloidosis patients with other genotypes (P < 0.0001). Conclusions: Because of low penetrance and as yet other undetermined reasons, mutation analysis of the most common MEFV mutations supports a clinical diagnosis in only about 60% of patients with definite FMF.
KW - Amyloidosis
KW - Familial
KW - MEFV gene
KW - Mediterranean fever
KW - Mutations
UR - http://www.scopus.com/inward/record.url?scp=0041402652&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0041402652
SN - 1565-1088
VL - 5
SP - 585
EP - 588
JO - Israel Medical Association Journal
JF - Israel Medical Association Journal
IS - 8
ER -